Stay updated on HERV-W Antagonist GNbAC1 Clinical Trial
Sign up to get notified when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.

Latest updates to the HERV-W Antagonist GNbAC1 Clinical Trial page
- Check6 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, signaling a new version of the page without changes to substantive content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page shows Revision: v3.5.3, replacing the previous v3.5.2, indicating a minor update to the page's template or metadata. This change does not appear to alter the study details or user-facing information.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision metadata updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.4.3 is displayed on the page, replacing the previous v3.4.2.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision: v3.4.2 was added and the prior funding/operating-status notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to HERV-W Antagonist GNbAC1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.